847349-87-5

Basic information

• Product Name: 2-(Benzyloxy)-5-bromo-4-methylpyridine
• Synonyms: 2-(Benzyloxy)-5-bromo-4-methylpyridine;2-(Benzyloxy)-5-bromo-4-picoline
• CAS NO: 847349-87-5
• Molecular Formula: C₁₃H₁₂BrNO
• Molecular Weight: 278.14448
• Mol File: 847349-87-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(Benzyloxy)-5-bromo-4-methylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Benzyloxy)-5-bromo-4-methylpyridine(847349-87-5)
• EPA Substance Registry System: 2-(Benzyloxy)-5-bromo-4-methylpyridine(847349-87-5)

Safety Data

• Hazardous Substances Data: 847349-87-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(benzyloxy)-5-bromo-4-methylpyridine is utilized as a reagent or intermediate in the synthesis of complex molecules for medicinal purposes. Its unique structure allows for the creation of new pharmaceuticals with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(benzyloxy)-5-bromo-4-methylpyridine is employed as a precursor in the development of new agrochemicals. Its chemical properties contribute to the formulation of effective compounds for agricultural use, such as pesticides or herbicides.
Used in Materials Science:
2-(benzyloxy)-5-bromo-4-methylpyridine may also have potential applications in the field of materials science. Its unique chemical structure could be leveraged to develop new materials with specific properties for various industrial applications.
Used in Organic Synthesis:
As a key intermediate in organic synthesis, 2-(benzyloxy)-5-bromo-4-methylpyridine is used to construct a wide range of organic compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis of specialty chemicals and advanced materials.

Upstream product

• 100-51-6 benzyl alcohol 
• 778611-64-6 5-bromo-2-chloro-4-methylpyridine 
• 164513-38-6 5-bromo-4-methylpyridin-2(1H)-one 
• 100-39-0 benzyl bromide 

Downstream Products

• 1189757-59-2 n-propyl 6-(benzyloxy)-4-methylpyridine-3-carboxylate 

Relevant articles and documents

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

The compounds represented by Formula (I) or pharmaceutically acceptable salts thereof: with U, W, X, Y, Z, p and ring A as defined in claim 1. Those compounds are useful for the treatment or prevention of bacteria infections. The variables of Formula (I) are as described herein. Pharmaceutically acceptable compositions comprise the compounds of Formula (I) or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers, adjuvants, or vehicles. Methods of treating bacteria infections employ such compounds or pharmaceutically acceptable salts thereof.

1,2,4-oxadiazole derivatives and their therapeutic use

New derivatives of general formula (I), or pharmaceutically acceptable salts or N-oxides thereof wherein, A is selected from the group consisting of -N-, -O- and -S-; B and C are independently selected from the group consisting of-N- and -O-, with the proviso that at least two of A, B and C are nitrogen atoms; G1 is selected from the group consisting of -CH2-, -NH- and -O-; G2 is selected from the group consisting of -NR4- and -O-; R1 represents: ? a 8 to 10 membered bicyclic N-containing heteroaryl group optionally substituted with a C1-4 carboxyalkyl group or a C1-4 aminoalkyl group, ? a pyridyl group optionally substituted with one or more substituents selected from hydroxy groups, C1-4 alkyl groups, C1-4 carboxyalkyl groups, C1-4 haloalkyl groups, C1-4 alkoxy groups, amino groups, C1-4 aminoalkyl groups and C1-4 aminoalkoxy groups, ? a pyridone group substituted with one or more C1-4 alkyl groups; C1-4 haloalkyl groups or C1-4 aminoalkyl groups, or ? a group of formula: wherein: ? Ra represents a hydrogen atom, a halogen atom, a C1-4 alkyl group, C3-4 cycloalkyl group or a -CF3 group; ? Rb represents a hydrogen atom, a halogen atom, a C14 alkyl group, a -CF3 group or a C1-4 alkoxy group; ? Rd represents a hydrogen atom, a C1-4 alkyl group or a C1-4 alkoxy group; ? Rc represents: ○ a hydrogen atom, a C1-4 hydroxyalkyl group, a C1-4 aminoalkyl group which is optionally substituted with one or more substituents selected from halogen atoms, hydroxy groups and -CF3 groups; ○ a 4 to 6-membered saturated N-containing heterocyclic ring optionally substituted with a C1-2 carboxyalkyl group; ○ -(CH2)(0-4)-C(O)OR', -(CH2)(0-4)-C(O)NR'R", -(CH2)(0-4)-NHC(O)R", -S(O)2NR'R", -O-(CH2)(2-4)NR'R", -O-(CH2)(1-4)C(O)OR", -O-(CH2)(1-4)-C(O)NR'R", -(CH2)(0-4)-NR'R", -(CH2)(0-4)-CONHS(O)2R', -(CH2)(0-4)-NHS(O)2R' or -(CH2)(0-3)-N H-(CH2)(1-3)-(NH)(0-1)S(O)2R' wherein, ■ R' represents a hydrogen atom or a C1-4 alkyl group, ■ R" represents a hydrogen atom, a C1-4 alkyl group, a C3-4 cycloalkyl group, a C1-4 carboxyalkyl group, a C1-4 haloalkyl group, a C1-4 hydroxyalkyl group or a 6 membered, saturated N-containing heterocyclic ring, or ■ R' and R" together with the nitrogen atom to which they are attached from a 4 to 6 membered heterocyclic group which contains, as heteroatoms, one N atom and, optionally, one further atom selected from N and O, and which is optionally substituted with a carboxy or a C1-4 carboxyalkyl group, or Rc together with Rd form a C5-6 cycloalkyl group optionally substituted by a -NHRf group, wherein Rf is selected from the group consisting of a hydrogen atom and a carboxymethyl group; R2 and R3 are independently selected from the group consisting of hydrogen atoms, halogen atoms and C1-4 alkyl groups; and R4 is selected from the group consisting of a hydrogen atom, a phenyl group, a C3-4 cycloalkyl-C1-4 alkyl group, C1-4 aminoalkyl group, C1-4 haloalkyl group and a linear or branched C1-4 alkyl group which is optionally substituted by a phenyl or a pyridyl group.

Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor

A series of 2-pyridone-containing imidazoline derivatives was synthesized and evaluated as neuropeptide Y Y5 receptor antagonists. Optimization of the 2-pyridone structure on the 2-position of the imidazoline ring led to identification of 1-(difluoromethy